Fact: What you eat still matters
Aronne, MD, FACP is a world-renowned physician, researcher, professor, and leading expert in weight management and GLP-1 medications
For example, gastro-oesophageal reflux disease (GORD) is listed as a common side effect (affecting up to 1 in 10 people) with semaglutide (Wegovy), while dyspepsia (indigestion) is common with several agents in this class
First, the study population was drawn from a single country, making it difficult to generalize the results to other racial or ethnic backgrounds
An upright position keeps the liquid pooled under your tongue rather than running toward your throat
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035